References
- Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001; 344(22): 1688–1700.
- Troost D, van den Oord JJ, de Jong JM, Swaab DF. Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis. Clin Neuropathol 1989; 8(6): 289–294.
- Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunological reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 1992; 140(3): 691–707.
- Engelhardt JI, Tajti J, Appel SH. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol 1993; 50(1): 30–36.
- Lampson LA, Kushner PD, Sobel RA. Major histocompati- bility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis. Ann Neurol 1990; 28(3): 365– 372.
- Panzara MA, Gussoni E, Begovich AB et al. T-cell receptor BV gene rearrangements in the spinal cords and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Neurobiol Dis 1999; 6(5): 392–405.
- Sekizawa T, Openshaw H, Ohbo K, Sugamura K, Itoyama Y, Niland JC. Cerebrospinal fluid interleukin-6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases. J Neurol Sci 1998; 154(2): 194–199.
- Klimek A, Stepien H, Szulc-Kuberska J, Karpinska A, Zylinska K. The level of Interleukin-6 in patients with amyotrophic lateral sclerosis. Neurol Neurochir Pol 1995; 29(4): 537–544.
- Krieger C, Perry TL, Ziltener HJ. Amyotrophic lateral sclerosis: interleukin-6 levels in cerebrospinal fluid. Can J Neurol Sci 1992; 19(3): 357–359.
- Ono S, Hu J, Shimizu N, Imai T, Nakagawa H. Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis. J Neurol Sci 2001; 187(1–2): 27–34.
- Windhagen A, Newcombe J, Dangond F et al. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin-12 cytokine in multiple sclerosis lesions. J Exp Med 1995; 182(6): 1985–1996.
- Drulovic J, Mostarica-Stojkovic M, Levic Z, Stojsavljevic N, Pravica V, Mesaros S. Interleukin-12 and tumour necrosis factor- alpha levels in cerebrospinal fluid of multiple sclerosis patients. J Neurol Sci 1997; 147(2): 145–150.
- Fassbender K, Ragoschke A, Rossol S et al. Increased release of interleukin-12p40 in MS: association with intracerebral inflam- mation. Neurology 1998; 51(3): 753–758.
- Traugott U, Lebon P. Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions. J Neurol Sci 1988; 84(2–3): 257–264.
- Engelborghs S, De Brabander M, De Cree J et al. Unchanged levels of interleukins, neopterin, interferon-gamma and tumour necrosis factor-alpha in cerebrospinal fluid of patients with dementia of the Alzheimer type. Neurochem Int 1999; 34(6): 523–530.
- Ichiyama T, Shoji H, Kato M et al. Cerebrospinal fluid levels of cytokines and soluble tumour necrosis factor receptor in acute dis- seminated encephalomyelitis. Eur J Pediatr 2002; 161(3): 133–137.
- Matsubara T, Matsuoka T, Katayama K et al. Mononuclear cells and cytokines in the cerebrospinal fluid of echovirus 30 meningitis patients. Scand J Infect Dis 2000; 32(5): 471–474.
- Fassbender K, Mielke O, Bertsch T et al. Interferon-gamma- inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases. Neurology 1999; 53(5): 1104–1106.
- Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromus- cular Diseases and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’ workshop contributors. J Neurol Sci 1994; 124(suppl): 96–107.